Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 51 Neoplasms 29 Prostatic Neoplasms 28 Head and Neck Neoplasms 15 Lung Neoplasms 14 Ovarian Neoplasms 9 Pancreatic Neoplasms 8 Urinary Bladder Neoplasms 6 Sarcoma 6 Oropharyngeal Neoplasms 6 Hematologic Neoplasms 6 Gastrointestinal Neoplasms 6 Colorectal Neoplasms 6 Uterine Cervical Neoplasms 5 Rectal Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Esophageal Neoplasms 5 Endometrial Neoplasms 5 Depression 5 Brain Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Polycystic Ovary Syndrome 4 Motor Activity 4 Melanoma 4 Lymphoma 4 Anxiety Disorders 4 Stomach Neoplasms 3 Pain 3 Osteosarcoma 3

Interventions

pembrolizumab 44 Gemcitabine 23 enfortumab vedotin 21 Nivolumab 20 Cisplatin 17 avelumab 16 Magnetic Resonance Spectroscopy 15 Carboplatin 14 atezolizumab 13 Specimen Handling 12 Docetaxel 11 sacituzumab govitecan 9 Paclitaxel 8 Ipilimumab 8 durvalumab 6 Mitomycin 5 Fluorodeoxyglucose F18 5 cabozantinib 4 Taxes 4 toripalimab 3 pemigatinib 3 erdafitinib 3 X-Rays 3 Radiosurgery 3 Platinum 3 Pemetrexed 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 ALT-803 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Surveys and Questionnaires × 1 year × Clear all

NCT04566029 2025-12-10

AMI

Centre Hospitalier Universitaire de Nīmes

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡